Evidence map›Paper›PMID 22717186›Full record

ArticleContraception2012

Effect of injectable contraceptive use on response to antiretroviral therapy among women in Rakai, Uganda.

Chelsea B Polis, Gertrude Nakigozi, Victor Ssempijja, Fredrick E Makumbi, Iga Boaz, Steven J Reynolds, Anthony Ndyanabo, Tom Lutalo, Maria J Wawer, Ronald H Gray

Abstract read
In one paragraph

Article in Contraception, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chelsea B PolisJohns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. cpolis@jhsph.edu
Gertrude Nakigozi
Victor Ssempijja
Fredrick E Makumbi
Iga Boaz
Steven J Reynolds
Anthony Ndyanabo
Tom Lutalo
Maria J Wawer
Ronald H Gray

Funding

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Circumcision: HIV/STIs and behaviors in a RCT and post-RCT surveillance; RakaiU01AI075115 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2007 to 2011
$9.3M
Intramural NIH HHSNIAID NIH HHS 1UO1AI075115-O1A1NIAID NIH HHS U01 AI075115
6 · The paper itself

Abstract

backgroundThere is limited evidence on the effect of injectable contraception on response to antiretroviral therapy (ART).

designUsing modified Poisson regression, we assessed data from 418 female Ugandan ART initiators to examine the effect of injectable contraceptive use on a composite virologic failure outcome (defined as failure to achieve virologic suppression, switch to second line therapy, or death within 12 months of ART initiation) and also assessed ART adherence.

resultsAbout 12% of women reported using injectable contraceptives at ART initiation, and their composite virologic failure rates 12 months later were similar to women not using injectable contraceptives at ART initiation (11% vs. 12%, p=0.99). Multivariable Poisson regression suggested no significant differences in virologic failure by injectable contraceptive use at baseline (prevalence risk ratio: 0.85, p=0.71), but power was limited. Adherence to ART increased with time since ART initiation, and did not appear to differ between injectable contraceptive users and non-users.

conclusionsConsistent with current World Health Organization guidelines, our results suggest no deleterious effect of injectable contraceptive use on response to ART, but power was limited, injectable contraceptive use patterns over time were inconsistent and additional evidence is needed.

Indexed as

AdolescentAdultAnti-Retroviral AgentsCommunity Health ServicesContraceptive Agents, FemaleDrug ImplantsDrug InteractionsDrug MonitoringDrug Resistance, ViralFemaleFollow-Up StudiesHIV-1HIV InfectionsHumansLost to Follow-UpMedication AdherenceAnti-Retroviral AgentsContraceptive Agents, FemaleDrug ImplantsMedroxyprogesterone Acetate

Identifiers

PMID22717186
PMCPMC3449005

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.